Skip to content
10-Q

Quarterly Report

Stoke Therapeutics, Inc. STOK

0000950170-25-107332

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 54.8M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.35M sh
Shares Diluted Q2 2025 · Jun 30, 2025 59.68M sh
Shares Diluted Q2 2025 · Jun 30, 2024 55.77M sh
Shares Diluted Q2 2025 · Jun 30, 2024 51.29M sh
Capex Q2 2025 · Jun 30, 2025 $306K
Capex Q2 2025 · Jun 30, 2024 $58K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $106.41M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$42.04M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $101.47M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $127.98M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $193.48M
Stockholders Equity Q2 2025 · Jun 30, 2025 $334.94M
Stockholders Equity Q2 2025 · Mar 31, 2025 $350.07M
Stockholders Equity Q2 2025 · Dec 31, 2024 $229.02M
Stockholders Equity Q2 2025 · Jun 30, 2024 $242.71M
Stockholders Equity Q2 2025 · Mar 31, 2024 $140.34M
Stockholders Equity Q2 2025 · Dec 31, 2023 $159.57M
Current Liabilities Q2 2025 · Jun 30, 2025 $38.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $40.06M
Total Liabilities Q2 2025 · Jun 30, 2025 $49.57M
Total Liabilities Q2 2025 · Dec 31, 2024 $42.53M
Current Assets Q2 2025 · Jun 30, 2025 $269.97M
Current Assets Q2 2025 · Dec 31, 2024 $232.76M
Total Assets Q2 2025 · Jun 30, 2025 $384.51M
Total Assets Q2 2025 · Dec 31, 2024 $271.56M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.40
Eps Diluted Q2 2025 · Jun 30, 2025 $1.50
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.46
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.02
Eps Basic Q2 2025 · Jun 30, 2025 −$0.40
Eps Basic Q2 2025 · Jun 30, 2025 $1.54
Eps Basic Q2 2025 · Jun 30, 2024 −$0.46
Eps Basic Q2 2025 · Jun 30, 2024 −$1.02
Rd Expense Q2 2025 · Jun 30, 2025 $25.86M
Rd Expense Q2 2025 · Jun 30, 2025 $58.53M
Rd Expense Q2 2025 · Jun 30, 2024 $21.14M
Rd Expense Q2 2025 · Jun 30, 2024 $43.5M
Net Income Q2 2025 · Jun 30, 2025 −$23.48M
Net Income Q2 2025 · Jun 30, 2025 $89.4M
Net Income Q2 2025 · Mar 31, 2025 $112.88M
Net Income Q2 2025 · Jun 30, 2024 −$25.7M
Net Income Q2 2025 · Jun 30, 2024 −$52.07M
Net Income Q2 2025 · Mar 31, 2024 −$26.37M
Operating Income Q2 2025 · Jun 30, 2025 −$27.3M
Operating Income Q2 2025 · Jun 30, 2025 $83.94M
Operating Income Q2 2025 · Jun 30, 2024 −$29.34M
Operating Income Q2 2025 · Jun 30, 2024 −$57.71M
Revenue Q2 2025 · Jun 30, 2025 $13.82M
Revenue Q2 2025 · Jun 30, 2025 $172.39M
Revenue Q2 2025 · Jun 30, 2024 $4.83M
Revenue Q2 2025 · Jun 30, 2024 $9.05M